Fenoprofen calcium en es it fr

Fenoprofen calcium Brand names, Fenoprofen calcium Analogs

Fenoprofen calcium Brand Names Mixture

  • No information avaliable

Fenoprofen calcium Chemical_Formula

C24H33N3O4

Fenoprofen calcium RX_link

No information avaliable

Fenoprofen calcium fda sheet

Fenoprofen_calcium FDA

Fenoprofen calcium msds (material safety sheet)

Fenoprofen calcium Synthesis Reference

No information avaliable

Fenoprofen calcium Molecular Weight

427.537 g/mol

Fenoprofen calcium Melting Point

No information avaliable

Fenoprofen calcium H2O Solubility

Very slightly soluble

Fenoprofen calcium State

Solid

Fenoprofen calcium LogP

1.876

Fenoprofen calcium Dosage Forms

Tablets (extended release - 500 mg)

Fenoprofen calcium Indication

For the treatment of chronic angina. It should be used in combination with amlodipine, beta-blockers or nitrates.

Fenoprofen calcium Pharmacology

Ranolazine has antianginal and anti-ischemic effects that do not depend upon reductions in heart rate or blood pressure. It is the first new anti-anginal developed in over 20 years.

Fenoprofen calcium Absorption

Absorption is highly variable. After oral administration of ranolazine as a solution, 73% of the dose is systemically available as ranolazine or metabolites. The bioavailability of oral ranolazine relative to that from a solution is 76%.

Fenoprofen calcium side effects and Toxicity

In the event of overdose, the expected symptoms would be dizziness, nausea/vomiting, diplopia, paresthesia, and confusion. Syncope with prolonged loss of consciousness may develop.

Fenoprofen calcium Patient Information

AMITIZA™ may cause nausea. If this occurs, concomitant administration of food with AMITIZA™ may reduce symptoms of nausea. AMITIZA™ should not be administered to patients that have severe diarrhea. Patients should be aware of the possible occurrence of diarrhea during treatment. If the diarrhea becomes severe consult your physician.

Fenoprofen calcium Organisms Affected

Humans and other mammals